$QTTB 4/A SEC Filings

Filed On	Filing
21 Jul 2026	Form 4/A: Tzianabos Arthur, Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Lundberg Sven Ante, Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Laporte Kathleen, Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Iwicki Mark T, Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Xu Diyong, Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Manke Isaac, Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Grayzel David S., Director Granted 10,826 Stock Option (Right to Buy)
21 Jul 2026	Form 4/A: Thistle Mary, Director Granted 10,826 Stock Option (Right to Buy)
20 Jan 2023	Form 4/A: Blum Michael Lee, Chief Commercial Officer Holds 9,408 shares of Common Stock
20 Jan 2023	Form 4/A: Alloway Paul, See Remarks Holds 16,706 shares of Common Stock
20 Jan 2023	Form 4/A: Seymour Albert, Director Holds 147,702 shares of Common Stock
08 Sep 2021	Form 4/A: Kelly Timothy P, See Remarks Sold 6,232 shares ($69.6K)
11 Jun 2019	Form 4/A: Wheeler Cameron, Director Granted 15,580 Option (Right to Buy)
16 May 2018	Form 4/A: Shah Mahendra, Director Received 250,000 shares as a grant or award ($4M)
04 Apr 2018	Form 4/A: Parmar Kush, Director Received 5,392,037 shares by conversion

Comments